Filter
801
Text search:
rifampicin
Featured
Recommendations
111
New Publications
241
Language
Document type
No document type
566
Guidelines
104
Studies & Reports
61
Manuals
28
Fact sheets
13
Strategic & Response Plan
12
Training Material
9
Situation Updates
4
Infographics
2
App
1
Resource Platforms
1
Countries / Regions
India
57
Western and Central Europe
56
Eastern Europe
32
Nepal
23
South Africa
23
Kenya
19
Tanzania
16
Nigeria
14
Germany
13
Namibia
13
Ethiopia
12
Uganda
12
Zambia
12
Bangladesh
12
Global
11
Malawi
10
Philippines
9
Cambodia
9
Myanmar / Burma
9
South–East Asia Region
9
Latin America and the Carribbean
9
Ukraine
8
Rwanda
7
Asia
7
Russia
6
Eswatini/ Swaziland
5
Africa
5
Tajikistan
5
Indonesia
4
Botswana
4
Sierra Leone
3
Ghana
3
Zimbabwe
3
Pakistan
3
Mozambique
3
Argentina
3
Colombia
3
Lesotho
3
Bhutan
3
Georgia
3
Liberia
2
Senegal
2
Syria
2
Benin
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Armenia
2
Timor Leste/ East Timor
2
Burkina Faso
1
Congo, Democratic Republic of
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Malaysia
1
Sudan
1
Brazil
1
North Macedonia
1
Switzerland
1
Serbia
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Solomon Islands
1
North Korea
1
Albania
1
Laos
1
Romania
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
109
Public Health
18
Women & Child Health
18
Capacity Building
16
Pharmacy & Technologies
12
Key Resources
5
Toolboxes
TB
352
HIV
75
NTDs
39
AMR
27
Pharmacy
26
Refugee
15
Polio
10
Ebola
5
Caregiver
5
Conflict
4
COVID-19
4
Mental Health
3
Global Health Education
3
Rapid Response
2
Natural Hazards
1
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
Technical and operational ‘how-to’: practical considerations
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of conta
...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evi
...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Lepro
...
Guidance for health workers
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
HIV & AIDS Treatment in Practice No. 198
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive
...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
